PRINCIPAL FINANCIAL GROUP INC

Position in COGT — Cogent Biosciences, Inc.

CIK 1126328 DES MOINES, IA

Position in COGT

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$4,843,614

+$1,612,610 QoQ

Shares Held

125,158

+49.1% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#126

of 321 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. COGT ranks #45 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	873,502	$232,980,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	389,511	$193,481,798
3	CYTK	Cytokinetics Inc	1,311,664	$111,740,655
4	GPCR	Structure Therapeutics Inc.	1,752,753	$94,070,253
5	INSM	INSMED Inc	856,126	$91,280,154
6	AXSM	Axsome Therapeutics, Inc.	332,642	$81,420,782
7	BBIO	BridgeBio Pharma, Inc.	1,024,423	$76,299,024
8	REGN	Regeneron Pharmaceuticals, Inc.	121,053	$75,481,386

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,843,614	125,158	+49.1%	Shares	Defined	2026-08-04
2026-03-31	$3,231,004	83,944	-24.9%	Shares	Defined	2026-05-04
2025-12-31	$3,971,349	111,806	-59.0%	Shares	Defined	2026-02-02
2025-09-30	$3,912,525	272,460	+1580.7%	Shares	Defined	2025-11-04
2024-06-30	$136,657	16,211	-18.6%	Shares	Defined	2024-07-29
2024-03-31	$133,828	19,915	-1.1%	Shares	Defined	2024-04-29
2023-12-31	$118,440	20,143	-5.3%	Shares	Defined	2024-02-07
2023-09-30	$207,352	21,267	+15.2%	Shares	Defined	2023-11-02
2023-06-30	$218,613	18,464	+8.1%	Shares	Defined	2023-08-07
2023-03-31	$184,347	17,085	+17.2%	Shares	Defined	2023-05-09
2022-12-31	$168,544	14,580	—	Shares	Defined	2023-02-09
No filing history on record for this holder in this stock.